These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 39293565)

  • 1. Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10.
    Yang Y; Lu J; Liu Y; Zhang N; Luo Y; Ma M; Dong Z; Zhang S; Zheng MH; Ruan CC; Wan X; Hu C; Lu Y; Ma X; Zhou B
    Mol Metab; 2024 Nov; 89():102030. PubMed ID: 39293565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation.
    Liu H; Xu L; Yue S; Su H; Chen X; Liu Q; Li H; Liang H; Chen X; He J; Ding Z; Zhang B
    Cancer Commun (Lond); 2024 Sep; 44(9):1018-1041. PubMed ID: 39030964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of NAT10 alleviates maternal high-fat diet-induced hepatic steatosis in male offspring of mice.
    Zhang QR; Zhang JB; Shen F; Xue R; Yang RX; Ren TY; Fan JG
    Obesity (Silver Spring); 2024 Jul; 32(7):1349-1361. PubMed ID: 38816990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcytidine modification of Amotl1 by N-acetyltransferase 10 contributes to cardiac fibrotic expansion in mice after myocardial infarction.
    Wang XX; Zhao YM; Zhang QY; Zhao JX; Yin DH; Zhang ZZ; Jin XY; Li SN; Ji HY; Chen HY; Guo XF; Yu Y; Ma WY; Yan H; Li H; Ou-Yang QM; Pan ZW; Liang HH; Wang N; Chen W; Cai BZ; Liu Y
    Acta Pharmacol Sin; 2024 Jul; 45(7):1425-1437. PubMed ID: 38839936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD).
    Lopez-Pascual A; Russo-Cabrera JS; Ardaiz N; Palmer T; Graham AR; Uriarte I; Gomar C; Ruiz-Guillamon D; Latasa MU; Arechederra M; Fontanellas A; Monte MJ; Marin JJG; Berasain C; Del Rio CL; Fernandez-Barrena MG; Martini PGV; Schultz JR; Berraondo P; Avila MA
    Clin Sci (Lond); 2024 Oct; 138(20):1265-1284. PubMed ID: 39301694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetyltransferase 10 regulates alphavirus replication via N4-acetylcytidine (ac4C) modification of the lymphocyte antigen six family member E (LY6E) mRNA.
    Dang Y; Li J; Li Y; Wang Y; Zhao Y; Zhao N; Li W; Zhang H; Ye C; Ma H; Zhang L; Liu H; Dong Y; Yao M; Lei Y; Xu Z; Zhang F; Ye W
    J Virol; 2024 Jan; 98(1):e0135023. PubMed ID: 38169284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice.
    Caputo M; Andersson E; Xia Y; Hou W; Cansby E; Erikson M; Lind DE; Hallberg B; Amrutkar M; Mahlapuu M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression.
    Wang G; Zhang M; Zhang Y; Xie Y; Zou J; Zhong J; Zheng Z; Zhou X; Zheng Y; Chen B; Liu C
    Clin Transl Med; 2022 May; 12(5):e738. PubMed ID: 35522942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK/mTOR signalling through N4-acetylcytidine modification of SLC30A9.
    Ding M; Yu Z; Lu T; Hu S; Zhou X; Wang X
    Clin Transl Med; 2024 Jul; 14(7):e1747. PubMed ID: 38961519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of NAT10 Reduces the Translation of
    Xu T; Du T; Zhuang X; He X; Yan Y; Wu J; Zhou H; Li Y; Liao X; He J; Liu C; Dong Y; Ou J; Lin S; Chen D; Huang ZP
    J Am Heart Assoc; 2024 Oct; 13(20):e035714. PubMed ID: 39392166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of hepatic ChREBP⍺-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD/MASH.
    Zhang D; Zhao Y; Zhang G; Lank D; Cooke S; Wang S; Nuotio-Antar A; Tong X; Yin L
    Mol Metab; 2024 Jul; 85():101957. PubMed ID: 38740087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotic Mixture Ameliorates a Diet-Induced MASLD/MASH Murine Model through the Regulation of Hepatic Lipid Metabolism and the Gut Microbiome.
    Zhang F; Lo EKK; Chen J; Wang K; Felicianna ; Ismaiah MJ; Leung HKM; Zhao D; Lee JC; El-Nezami H
    J Agric Food Chem; 2024 Apr; 72(15):8536-8549. PubMed ID: 38575146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of STK39 weakens the MASLD/MASH process by protecting the intestinal barrier.
    Xu Q; Liu F; Wu Z; Chen M; Zhou Y; Shi Y
    Biosci Trends; 2024 Jul; 18(3):289-302. PubMed ID: 38925962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation.
    Shi J; Yang C; Zhang J; Zhao K; Li P; Kong C; Wu X; Sun H; Zheng R; Sun W; Chen L; Kong X
    Circ Res; 2023 Dec; 133(12):989-1002. PubMed ID: 37955115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choline-deficient, high-fat diet-induced MASH in Göttingen Minipigs: characterization and effects of a chow reversal period.
    Hvid H; Hjuler ST; Bedossa P; Tiniakos DG; Kamzolas I; Harder LM; Xue Y; Perfield JW; Kirk RK; Latta M; Mikkelsen LF; Pedersen HD;
    Am J Physiol Gastrointest Liver Physiol; 2024 Oct; 327(4):G571-G585. PubMed ID: 39041677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAT10 promotes synovial aggression by increasing the stability and translation of N4-acetylated PTX3 mRNA in rheumatoid arthritis.
    Liu D; Kuang Y; Chen S; Li R; Su F; Zhang S; Qiu Q; Lin S; Shen C; Liu Y; Liang L; Wang J; Xu H; Xiao Y
    Ann Rheum Dis; 2024 Aug; 83(9):1118-1131. PubMed ID: 38724075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAT10 and cytidine acetylation in mRNA: intersecting paths in development and disease.
    Achour C; Oberdoerffer S
    Curr Opin Genet Dev; 2024 Aug; 87():102207. PubMed ID: 38820741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid Trem2 ameliorates the progression of metabolic dysfunction-associated steatotic liver disease by regulating macrophage pyroptosis and inflammation resolution.
    Yu W; Zhang Y; Sun L; Huang W; Li X; Xia N; Chen X; Wikana LP; Xiao Y; Chen M; Han S; Wang Z; Pu L
    Metabolism; 2024 Jun; 155():155911. PubMed ID: 38609037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression.
    Gallego-Durán R; Ampuero J; Maya-Miles D; Pastor-Ramírez H; Montero-Vallejo R; Rivera-Esteban J; Álvarez-Amor L; Pareja MJ; Rico MC; Millán R; Robles-Frías MJ; Aller R; Rojas Á; Muñoz-Hernández R; Gil-Gómez A; Gato S; García-Lozano M; Arias-Loste MT; Abad J; Calleja JL; Andrade RJ; Crespo J; González-Rodríguez Á; García-Monzón C; Andreola F; Pericás JM; Jalan R; Martín-Bermudo F; Romero-Gómez M
    United European Gastroenterol J; 2024 Oct; 12(8):1056-1068. PubMed ID: 38894596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.
    Cuño-Gómiz C; de Gregorio E; Tutusaus A; Rider P; Andrés-Sánchez N; Colell A; Morales A; Marí M
    Biol Sex Differ; 2023 Nov; 14(1):85. PubMed ID: 37964320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.